The majority of p53 mutations found in cancers are missense mutations, which result in a single amino acid change in the protein. These mutations often occur in the DNA-binding domain of p53, impairing its ability to regulate target genes effectively. Some mutations can lead to the production of a dominant-negative effect, where the mutant p53 protein interferes with the function of any remaining wild-type p53.
